Erratum to: pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients

被引：0
|
作者：
Gabriele Buda
Enrico Orciuolo
Sara Galimberti
Matteo Pelosini
Mario Petrini
机构：
[1] Pisa University,Department of Oncology, Transplants and Advanced Technologies, Section of Hematology
来源：
Annals of Hematology | 2011年 / 90卷 / 7期
关键词：
D O I：
10.1007/s00277-011-1203-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：863 / 863
相关论文
共 50 条
  • [1] Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients
    Gabriele Buda
    Enrico Orciuolo
    Sara Galimberti
    Matteo Pelosini
    Mario Petrini
    [J]. Annals of Hematology, 2011, 90 : 1115 - 1116
  • [2] Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients
    Buda, Gabriele
    Orciuolo, Enrico
    Galimberti, Sara
    Pelosini, Matteo
    Petrini, Mario
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (09) : 1115 - 1116
  • [3] Non Pegylated Liposomal Doxorubicin in Combination with Dexamethasone and Lenalidomide (RMD) Is Active in Advanced MM
    Buda, Gabriele
    Orciuolo, Enrico
    Rousseau, Martina
    Galimberti, Sara
    Cecconi, Nadia
    Petrini, Mario
    [J]. BLOOD, 2014, 124 (21)
  • [4] A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma
    Berenson, J. R.
    Yellin, O.
    Kazamel, T.
    Hilger, J. D.
    Chen, C-S
    Cartmell, A.
    Woliver, T.
    Flam, M.
    Bravin, E.
    Nassir, Y.
    Vescio, R.
    Swift, R. A.
    [J]. LEUKEMIA, 2012, 26 (07) : 1675 - 1680
  • [5] A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma
    J R Berenson
    O Yellin
    T Kazamel
    J D Hilger
    C-S Chen
    A Cartmell
    T Woliver
    M Flam
    E Bravin
    Y Nassir
    R Vescio
    R A Swift
    [J]. Leukemia, 2012, 26 : 1675 - 1680
  • [6] Bortezomib in combination with pegylated liposomal doxorubicin for the treatment of multiple myeloma
    Manochakian, Rarni
    Miller, Kena C.
    Chanan-Khan, Asher Alban
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (04): : 266 - 271
  • [7] Bortezomib, liposomal doxorubicin and dexamethasone combination therapy for patients with relapsed or refractory multiple myeloma
    Falcone, A.
    Sanpaolo, G.
    Bodenizza, C.
    Carella, A. M.
    Dell'Olio, M.
    Mantuano, S.
    Melillo, L.
    Merla, E.
    Scalzulli, F.
    Cascavilla, N.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 147 - 148
  • [8] Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial
    Jakubowiak, Andrzej J.
    Griffith, Kent A.
    Reece, Donna E.
    Hofmeister, Craig C.
    Lonial, Sagar
    Zimmerman, Todd M.
    Campagnaro, Erica L.
    Schlossman, Robert L.
    Laubach, Jacob P.
    Raje, Noopur S.
    Anderson, Tara
    Mietzel, Melissa A.
    Harvey, Colleen K.
    Wear, Sandra M.
    Barrickman, Jennifer C.
    Tendler, Craig L.
    Esseltine, Dixie-Lee
    Kelley, Susan L.
    Kaminski, Mark S.
    Anderson, Kenneth C.
    Richardson, Paul G.
    [J]. BLOOD, 2011, 118 (03) : 535 - 543
  • [9] Bortezomib/pegylated liposomal doxorubicin combinations in multiple myeloma
    Reddy, GK
    D'Orazio, A
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2005, 6 (03): : 170 - 171
  • [10] Phase II Trial of Combination Therapy With Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Myeloma
    Jakubowiak, Andrzej J.
    Kendall, Tara
    Al-Zoubi, Ammar
    Khaled, Yasser
    Mineishi, Shin
    Ahmed, Asra
    Campagnaro, Erica
    Brozo, Christine
    Braun, Thomas
    Talpaz, Moshe
    Kaminski, Mark S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) : 5015 - 5022
12345